Leishmaniasis: a review.
Torres-Guerrero E, Quintanilla-Cedillo MR, Ruiz-Esmenjaud J, Arenas R. · 2017
Read Leishmaniasis: a review. by Torres-Guerrero E, Quintanilla-Cedillo MR, Ruiz-Esmenjaud J, Arenas R. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5464238.txt.
Introduction
Torres-Guerrero and co-authors review leishmaniasis, a parasitic disease spread by sand fly bites. Their review appeared in F1000Research. The parasite lives inside host cells. It is endemic across Asia, Africa, and the Americas. The Mediterranean region is affected too. Some 350 million people live at risk. New cases run 1.5 to 2 million yearly. Deaths reach about 70,000 per year. The World Health Organization ranks it among seven top tropical diseases.
Clinical form depends on parasite species and host immunity. Localized skin ulcers mark the mildest form. Visceral disease can prove fatal. Mexico's characteristic form eats into cartilage. It is nicknamed chiclero's ulcer there. Ninety percent of visceral cases cluster in six countries. India, Sudan, and Brazil head that list. Cutaneous cases concentrate in ten countries. War-driven migration is reshaping the map. Treatment relies on pentavalent antimonials. They remain the only effective option cited.
Catalog record
| CREATOR | Torres-Guerrero E, Quintanilla-Cedillo MR, Ruiz-Esmenjaud J, Arenas R. |
|---|---|
| YEAR | 2017 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 67 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Leishmaniasis: a review By Edoardo Torres-Guerrero, Marco Romano Quintanilla-Cedillo, Julieta Ruiz-Esmenjaud, Roberto Arenas Published in: F1000Research DOI: 10.12688/f1000research.11120.1 ABSTRACT Abstract Leishmaniasis is caused by an intracellular parasite transmitted to humans by the bite of a sand fly. It is endemic in Asia, Africa, the Americas, and the Mediterranean region. Worldwide, 1.5 to 2 million new cases occur each year, 350 million are at risk of acquiring the disease, and leishmaniasis causes 70,000 deaths per year. Clinical features depend on the species of Leishmania involved and the immune response of the host. Manifestations range from the localized cutaneous to the visceral form with potentially fatal outcomes. Many drugs are used in its treatment, but the only effective treatment is achieved with current pentavalent antimonials. Keywords: Leishmaniasis, Leishmania, cutaneous-chondral, chicleros ulcer INTRODUCTION Leishmaniasis is a tropical and subtropical disease caused by an intracellular parasite transmitted to humans by the bite of a sand fly, mainly Phlebotomus and Lutzomyia (Europe, Northern Africa, the Middle East, Asia, and part of South America); exceptionally, transmission has also been reported as a laboratory accident 1. According to the World Health Organization (WHO), leishmaniasis is one of the seven most important tropical diseases and it represents a serious world health problem that presents a broad spectrum of clinical manifestations with a potentially fatal outcome 2, 3. It is found in all continents except Oceania 2, 4 and is endemic in circumscribed geographic areas in Northeastern Africa, Southern Europe, the Middle East, Southeastern Mexico, and Central and South America. The clinical features include a broad range of manifestations with different degrees of severity that depend on the species of Leishmania involved and the immune response of the host 3. In Mexico, the most characteristic form is the cutaneous-chondral form 1, 4, also called “chiclero’s ulcer”. EPIDEMIOLOGY Leishmaniasis is a disease with a worldwide distribution; it is found in about 89 countries 4, 5. It is endemic in Asia, Africa, the Americas, and the Mediterranean region. In the American continent, it is mainly a jungle zoonosis (but it can be acquired in semi-desert or cold regions) transmitted by sand flies mainly of the genera Phlebotomus and Lutzomyia. It is found in many countries, from the southern United States to the northern provinces of Argentina (seroprevalence of 0.17% for cutaneous leishmaniasis [CL]) 6 with the exceptions of Chile, Uruguay, and El Salvador 4, 7, 8. Between 12 and 15 million people in the world are infected, and 350 million are at risk of acquiring the disease. An estimated 1.5 to 2 million new cases occur each year, and it causes 70,000 deaths per year 4, 9. In 2012, the WHO led an effort to report on the burden and distribution of leishmaniasis in 102 countries, areas, or territories worldwide—to identify cases of CL and visceral leishmaniasis (VL)—and the data until 2010 indicate that 90% of global cases of VL occurred in Bangladesh, Brazil, Ethiopia, India, South Sudan, and Sudan and that about 70% of CL cases occurred in Afghanistan, Algeria, Brazil, Colombia, Costa Rica, Ethiopia, Iran, Sudan, and the Syrian Arab Republic. On the other hand, of 25 countries selected to study the burden of this disease, 13 have a high burden of VL (Bangladesh, China, Ethiopia, Georgia, India, Kenya, Nepal, Paraguay, Somalia, South Sudan, Spain, Sudan, and Uganda), 11 have a high burden of CL (Afghanistan, Algeria, Colombia, Iran, Morocco, Pakistan, Peru, Saudi Arabia, Syrian Arab Republic, Tunisia, and Turkey), and one (Brazil) has a high burden of both clinical forms 10. In Turkey, around 2,000 autochthonous cases of CL are reported each year. Owing to the civil war in Syria, Turkey received around 3 million refugees, and they are located mainly at either camps or homes in the south or southeastern part of Turkey. An epidemiological study conducted in Turkey from 2009 to 2015 with 263 patients positive for leishmaniasis using real-time and semi-nested polymerase chain reactions (PCRs) revealed that 66.15% were Turkish, 33.46% were Syrian, and 0.38% were Afghani; the species detected were Leishmania tropica and Leishmania infantum (from Turkish and Syrian patients), demonstrating the effects of the war in that territory 11. Khezzani and Bouchemal, in Algeria, reported 4,813 confirmed cases of CL in a period of 13 years: the disease affected all municipalities and all age groups 12. The most affected individuals were 10 to 19 years old (31.41%) and children less than 9 years old (25.70%). Most of the patients were males (65%). In Iran, Holakouie-Naieni et al. identified the geographic and seasonal distribution of CL: there were 589,913 cutaneous cases, the annual incidence was approximately 30.9 per 100,000 and most cases occurred in the central regions of the country 13, and the highest prevalence rate (35.14%) of lesions occurred in autumn 14. VL, also known as kala-azar, is a clinical form endemic in Bangladesh, India, and Nepal. More than 60% of all VL cases worldwide correspond to South Asia, with a predominance in rural areas. In this respect, in Nepal, approximately 5.7 million people are considered to be at risk and are confined mainly to the Terai region, which borders the VL-endemic districts of the Bihar state in India. Moreover, from 1980 to 2007, a total of 23,368 cases, including 311 deaths, were reported. According to the annual health report of the Department of Health Services in Nepal, the incidence of VL was 2.67 per 10,000 people at risk in 2006–2007 15. In Latin America, it is estimated that around 60,000 new cases (including all types) occur each year. The disease is typical of environments with an altitude of 0 to 1,500 m above sea level, temperatures higher than 20°C, and an annual rainfall of 1,500 to 3,000 mm. However, some cases known locally as “Uta” have been documented in the highlands of Peru, which are cold and humid places where the disease is transmitted by a small insect 16, 17. More commonly, it affects men, and in Mexico the main risks are seen among farmers (gum tree harvesters, cocoa and banana farmers, among others), loggers, hunters, precious timber exploiters, military personnel, biologists, ornithologists, and those who practice ecological tourism; it affects the collectors of yerba mate (tea), rubber, banana, coffee, and coca in Peru and Brazil 1, 17, 18. Women, the elderly, and children are also at risk of exposure in endemic zones. In Mexico, the disease has been known since the pre-Hispanic era 18, and all of the clinical forms of leishmaniasis have been reported 19. The most common presentations are the pure cutaneous and the cutaneous-chondral forms, which when affecting the ear cause the classic chiclero’s ulcer (gum tree harvester’s ulcer). The main endemic area in this country is found in the Neotropical zone from the southeast (southern Veracruz, Tabasco, Oaxaca, Chiapas, Campeche, Quintana Roo, and part of Yucatán) 1, 2, 7, 18, 20 ( Figure 1). In this country, an annual incidence of 5.08 cases per 100,000 population has been observed in the Yucatán Peninsula 21, 22. Serological studies carried out in Becanchén (southern state of Yucatán) have documented specific antibodies in 17% of the general population. Also, in Tabasco, an incidence and prevalence rate of 2.35 and 9.41 per 100,000 population, respectively, have been observed; therefore, it is